id: pharmaceutical_drug_cost_to_inflammatory_disease_treatment_access
name: Cost of Existing Anti-inflammatory Drugs â†’ Access to Inflammatory Disease Treatment
from_node:
  node_id: pharmaceutical_drug_cost
  node_name: Cost of Existing Anti-inflammatory Drugs
to_node:
  node_id: inflammatory_disease_treatment_access
  node_name: Access to Inflammatory Disease Treatment
direction: negative
category: economic
mechanism_pathway:
- 'Step 1: Existing anti-inflammatory therapeutic drugs have high costs that create
  economic barriers to access'
- 'Step 2: High drug costs limit treatment availability for low-income populations
  and in resource-limited settings'
- 'Step 3: Reduced access to anti-inflammatory treatment leads to uncontrolled inflammatory
  responses'
- 'Step 4: Uncontrolled inflammation triggers inflammatory cascades that threaten
  human and animal health'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Zhen Yang et al. 2023. "Study on the Alleviating Effect and Potential
    Mechanism of Ethanolic Extract of ." *International journal of molecular sciences*.
    https://doi.org/10.3390/ijms242216272
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.139321'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: systemic_side_effects
  direction: strengthens
  strength: moderate
  description: Susceptibility to systemic side effects from existing drugs further
    constrains their use, compounding the access barriers created by high costs
